Molecular mechanism of fatty acid activation of FFAR1.


Journal

Proceedings of the National Academy of Sciences of the United States of America
ISSN: 1091-6490
Titre abrégé: Proc Natl Acad Sci U S A
Pays: United States
ID NLM: 7505876

Informations de publication

Date de publication:
30 05 2023
Historique:
medline: 24 5 2023
pubmed: 22 5 2023
entrez: 22 5 2023
Statut: ppublish

Résumé

FFAR1 is a G-protein-coupled receptor (GPCR) that responds to circulating free fatty acids to enhance glucose-stimulated insulin secretion and release of incretin hormones. Due to the glucose-lowering effect of FFAR1 activation, potent agonists for this receptor have been developed for the treatment of diabetes. Previous structural and biochemical studies of FFAR1 showed multiple sites of ligand binding to the inactive state but left the mechanism of fatty acid interaction and receptor activation unknown. We used cryo-electron microscopy to elucidate structures of activated FFAR1 bound to a G

Identifiants

pubmed: 37216523
doi: 10.1073/pnas.2219569120
pmc: PMC10235965
doi:

Substances chimiques

Insulin 0
Fatty Acids 0
Ligands 0
Receptors, G-Protein-Coupled 0
Fatty Acids, Nonesterified 0
Glucose IY9XDZ35W2

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2219569120

Subventions

Organisme : NIGMS NIH HHS
ID : R35 GM131687
Pays : United States

Références

Expert Opin Ther Pat. 2020 Jan;30(1):27-38
pubmed: 31771391
Mol Pharmacol. 2012 Nov;82(5):843-59
pubmed: 22859723
PLoS One. 2013 Oct 10;8(10):e76280
pubmed: 24130766
Nat Commun. 2022 Jun 8;13(1):3186
pubmed: 35676276
Nat Commun. 2018 Sep 13;9(1):3712
pubmed: 30213947
Nature. 2014 Sep 4;513(7516):124-7
pubmed: 25043059
Nat Struct Mol Biol. 2017 Jul;24(7):570-577
pubmed: 28581512
Acta Crystallogr D Biol Crystallogr. 2010 Apr;66(Pt 4):486-501
pubmed: 20383002
J Biol Chem. 2000 Sep 1;275(35):27045-54
pubmed: 10854433
Acta Crystallogr D Struct Biol. 2019 Oct 1;75(Pt 10):861-877
pubmed: 31588918
Cell. 2020 Sep 17;182(6):1574-1588.e19
pubmed: 32946782
Int J Mol Sci. 2021 Feb 10;22(4):
pubmed: 33578942
Nat Methods. 2017 Apr;14(4):331-332
pubmed: 28250466
PLoS Biol. 2021 Jun 4;19(6):e3001295
pubmed: 34086670
Nucleic Acids Res. 2016 Jul 8;44(W1):W344-50
pubmed: 27166375
J Lipid Res. 2010 Jan;51(1):120-31
pubmed: 19625735
Science. 2019 May 10;364(6440):552-557
pubmed: 31073061
J Biol Chem. 2002 Oct 25;277(43):40989-96
pubmed: 12167654
Methods Enzymol. 2010;484:569-90
pubmed: 21036251
J Comput Chem. 2004 Oct;25(13):1605-12
pubmed: 15264254
Nature. 2020 Aug;584(7819):125-129
pubmed: 32528175
J Struct Biol. 2016 Jan;193(1):1-12
pubmed: 26592709
Science. 2022 Sep 30;377(6614):eabn7065
pubmed: 36173843
J Biol Chem. 1996 Jan 5;271(1):496-504
pubmed: 8550609
Nature. 2007 Nov 15;450(7168):383-7
pubmed: 17952055
Cell. 2019 Jan 24;176(3):448-458.e12
pubmed: 30639101
Phys Rev A Gen Phys. 1985 Mar;31(3):1695-1697
pubmed: 9895674
Protein Sci. 2022 Jan;31(1):209-220
pubmed: 34716622
Nature. 2011 Jul 19;477(7366):549-55
pubmed: 21772288
Br J Pharmacol. 2006 Jun;148(3):279-90
pubmed: 16582932
Nature. 2015 Aug 20;524(7565):315-21
pubmed: 26245379
Physiol Rev. 2020 Jan 1;100(1):171-210
pubmed: 31487233
J Biol Chem. 2009 Feb 6;284(6):3529-36
pubmed: 19068482
J Chem Phys. 2020 Jul 28;153(4):044130
pubmed: 32752662
Nat Rev Drug Discov. 2021 Sep;20(9):710-722
pubmed: 34257432
Chem Rev. 2017 Jan 11;117(1):67-110
pubmed: 27299848
Science. 2007 Nov 23;318(5854):1266-73
pubmed: 17962519
Science. 2019 Jun 28;364(6447):1283-1287
pubmed: 31249059
Nat Commun. 2018 Apr 25;9(1):1645
pubmed: 29695780
Mol Pharmacol. 2007 Apr;71(4):994-1005
pubmed: 17200419
J Am Chem Soc. 2004 Mar 24;126(11):3477-87
pubmed: 15025475
Biochemistry. 2009 Jun 9;48(22):4789-97
pubmed: 19378975
J Biol Chem. 2003 Mar 28;278(13):11303-11
pubmed: 12496284
Clin Trials. 2019 Jun;16(3):253-262
pubmed: 30880443
Nat Commun. 2022 May 25;13(1):2902
pubmed: 35614071
Elife. 2018 Nov 09;7:
pubmed: 30412051
Bioorg Med Chem Lett. 2021 Jun 1;41:127969
pubmed: 33771587
J Med Chem. 2007 Jun 28;50(13):2981-9
pubmed: 17552505
Nature. 2018 Jun;558(7711):547-552
pubmed: 29899455
Nat Methods. 2017 Jan;14(1):71-73
pubmed: 27819658
Nat Methods. 2012 Oct;9(10):1021-9
pubmed: 22983457
Nature. 2003 Mar 13;422(6928):173-6
pubmed: 12629551
Nat Chem Biol. 2021 Dec;17(12):1238-1244
pubmed: 34556862
Proc Natl Acad Sci U S A. 2007 May 1;104(18):7682-7
pubmed: 17452637
J Biol Chem. 2001 Aug 3;276(31):29171-7
pubmed: 11375997

Auteurs

Punita Kumari (P)

Department of Biophysics, The University of Texas Southwestern Medical Center, Dallas, TX 75390.

Asuka Inoue (A)

Department of Pharmaceutical Sciences, Tohoku University, Sendai 980-8578, Japan.

Karen Chapman (K)

Department of Biophysics, The University of Texas Southwestern Medical Center, Dallas, TX 75390.

Peng Lian (P)

BioHPC at the Lyda Hill Department of Bioinformatics, The University of Texas Southwestern Medical Center, Dallas, TX 75390.

Daniel M Rosenbaum (DM)

Department of Biophysics, The University of Texas Southwestern Medical Center, Dallas, TX 75390.

Articles similaires

Photosynthesis Ribulose-Bisphosphate Carboxylase Carbon Dioxide Molecular Dynamics Simulation Cyanobacteria
Receptor, Cannabinoid, CB1 Ligands Molecular Dynamics Simulation Protein Binding Thermodynamics
Cryoelectron Microscopy Algorithms Image Processing, Computer-Assisted Consensus Software

Amyloid accelerator polyphosphate fits as the mystery density in α-synuclein fibrils.

Philipp Huettemann, Pavithra Mahadevan, Justine Lempart et al.
1.00
Polyphosphates alpha-Synuclein Humans Amyloid Molecular Dynamics Simulation

Classifications MeSH